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Abstract
Background: Mucins are highly glycosylated proteins protecting and lubricating epithelial surface of respiratory,
gastrointestinal and reproductive tracts. Members of the mucin protein family have been suggested to play an
important role in development of endometriosis and infertility. This study investigates genetic association of
mucin2 (MUC2) with the risk of endometriosis and endometriosis-related infertility.
Methods: This case-control study was conducted at China Medical University Hospital, with 195 endometriosis
patients and 196 healthy controls enrolled. Genotyping of six SNPs (rs2856111, rs11245936, rs10794288, rs10902088,
rs7103978 and rs11245954) within MUC2 gene were performed by using Taqman genotyping assay; individual SNP
and haplotype associations with endometriosis and endometriosis-related infertility were assessed by c2 test.
Results: Endometriosis patients exhibit significantly lower frequency of the rs10794288 C allele, the rs10902088 T
allele and the rs7103978 G allele (P = 0.030, 0.013 and 0.040, respectively). In addition, the rs10794288 C allele and
the rs10902088 T allele were also less abundant in patients with infertility versus fertile ones (P = 0.015 and 0.024,
respectively). Haplotype analysis of the endometriosis associated SNPs in MUC2 also showed significantly
association between the most common haplotypes and endometriosis or endometriosis-related infertility.
Conclusions: MUC2 polymorphisms, especially rs10794288 and rs10902088, are associated with endometriosis as
well as endometriosis-related infertility. Our data present MUC2 as a new candidate involved in development of
endometriosis and related infertility in Taiwanese Han women.
Background
Endometriosis is a common chronic gynecologic disease
defined as presence of endometrial tissue outside the
uterine cavity, primarily on pelvic peritoneum and
ovary. Epidemiology studies reveal that endometriosis
affects more than 10% of reproductive age women and
possibly causes infertility [1,2]. The prevalence of endo-
metriosis was 0.5-5% in fertile and 25-45% in infertile
women [3]. The mechanism underlying endometriosis
development remains unclear, even though theories like
implantation, altered immunity, and susceptible genetic
factors have been proposed to explain the pathogenesis
[4-6]. Nevertheless, familial and identical twins studies
have established the genetic predisposition to endome-
triosis development [7].
Clinical manifestation of endometriosis is accompa-
nied by angiogenesis and formation of cellular adhesion
[8,9], possibly due to altered peritoneal environment and
immune system [10]. In endometriosis patients, changes
in levels of growth factors, cytokines and oncofetal anti-
gens may facilitate intraperitoneal endometrial growth
and alter the peritoneal environment, which leads to dis-
ruption of normal pelvic organ architectures and inferti-
lity [8]. For instance, interluekin-1 (IL-1), interleukin-6
(IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10),
nuclear factor-B (NF-B) and tumor necrosis factor-
alpha (TNF-a) are among the major cytokines partici-
pating in regulation of immune system, angiogenesis,
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cell proliferation and tissue invasiveness during the for-
mation of endometriosis [11-14].
Mucins are high molecular weight glycoproteins with
function of protecting and lubricating epithelial surface
of respiratory, gastrointestinal and reproductive tracts
[15]. Mucins are also found to be expressed on activated
lymphocytes, supporting the hypothesis that some
mucin domains function as cytokines to mediate
immune responses [16,17]. Early studies reported that
mucin played important role in the progress of tumor
invasion, which is influenced by their glycosylation sta-
tus [15,18-20]. More recently, mucin1 (MUC1) has been
reported to be linked to endometriosis and infertility
[21,22], and mucin4 (MUC4) gene polymorphisms were
proved to be associated with endometriosis development
as well [23]. The human mucin2 (MUC2) gene is
located on chromosome 11p15.5, encoding one of the
most common gel-forming secreted type of mucin [24].
MUC2 expression was reported to be regulated by many
endometriosis-related cytokines, such as IL-1b, IL-6,
TNF-a, NF-Kappa B [9,25-27]. Abnormal increase of
mucin2 (MUC2) expression was reported to be linked
to intestinal and uterine cervix metaplasia progression
[28,29].
However, there has been no study yet investigating the
relationship between endometriosis and MUC2, while
previous functional studies on MUC2 are more focused
on its role in the gastrointestinal and respiratory tract
[30,31].
The aim of this study was to investigate the possible
association of MUC2 gene polymorphisms with the risk
of endometriosis and endometriosis-related clinical
symptoms in a Taiwanese population.
Methods
Subjects
In all, 195 patients receiving surgery for ovarian benign
disease and pathology-proven endometriosis patients
were identified at China Medical University Hospital
from 1998-2011 and enrolled in the study. They
accepted examination of ultrasound before operation
and were diagnosed with ovarian cysts; symptoms of
dysmenorrhea, lower abdominal pain, infertility or
abnormal menstruation were recorded for each patient.
Another 196 healthy controls were recruited from a
pool of persons who received regular health checkups at
the same hospital. People with ovarian cysts detected by
ultrasound or any symptoms of dysmenorrhea, lower
abdominal pain, infertility, abnormal menstruation were
excluded from the controls. Both patients and controls
share similar age profile. Clinical information of patients
was collected from medical charts, including clinical
stage, lesion size, location, drug treatment and fertility.
The definition of endometriosis staging was based on
criteria of the American Society for Reproductive Medi-
cine: stage 1, minimal; stage 2, mild; stage 3, moderate;
and stage 4, severe [32]. Individual leukocytes were
drawn by vein-puncture and separated by Ficoll-paque
(GE, Uppsala, Sweden) for genomic DNA isolation.
Signed consent was obtained from each study subject,
approved by the Institutional Review Board at China
Medical University Hospital.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes according to standard protocol (Genomic DNA
kit; Qiagen, Valencia, CA, USA). DNA fragments con-
taining target SNP sites were amplified by PCR using
the Taqman SNP genotyping assay system from Applied
Biosystems, Inc. (Carlsbad, CA, USA). The probe IDs
for these SNP sites were selected from the ABI SNP
genotyping databank http://www.allsnps.com and listed
in Additional file 1: Table S1. PCR amplification condi-
tions consisted of initial denaturation at 95°C for 5 min,
followed by 40 cycles of 95°C for 10 sec, and 56°C for
10 sec. Genetic variations were detected by reading the
fluorescence signals of PCR products. A positive fluores-
cent signal indicates a perfect match between the probe
and the tested DNA, thus identifying the allele type.
Statistical analysis
Allelic and genotypic frequency distributions for these
SNP sites in endometriosis patients and controls were
performed by c2 analysis using SPSS software (version
10.0, SPSS Inc. Chicago, Illinois, US). Allelic and genoty-
pic frequencies are expressed as percentages of the total
number of alleles and genotypes. Odds Ratios (ORs)
were calculated for allelic and genotypic frequencies
with 95% confident interval (95% CI). Adherence to the
Hardy-Weinberg equilibrium constant was confirmed by
c2 test with one degree of freedom by PLINK program
[33].
Haplotype association was analyzed using Bayesian
statistical method available in the program Phase 2.1
[34]. Lewontin’s coefficient D’ and the linkage disequili-
brium (LD) were determined between each pairs of bial-
lelic loci using absolute association (r2) [35]. Haploview
4.2 (Whitehead Institute for Biomedical Research, Cam-
bridge, MA) was used to examine the structure of the
LD block [36]. A p value of less than 0.05 was consid-
ered statistically significant.
Functional analyses and secondary structure prediction
Functional characterization and annotation of MUC2
were performed by aligning the sequence with func-
tional motifs in PROSITE protein domain database [37].
NetSurfP ver. 1.1 was used to predict the secondary
structure and surface accessibility of MUC2 [38] Relative
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and absolute surface accessibility were also calculated
for each residue.
Results
MUC2 polymorphisms and endometriosis
To test whether SNPs in MUC2 gene play role in endo-
metriosis development, a total of six SNPs were selected
for this study, with minor allelic frequencies over 4% in
Chinese Han population based on the information in
international HapMap project databank http://www.hap-
map.org (Additional file 1: Table S1). These SNPs and
their LD map were shown in Figure 1A. Genotype and
allele frequencies were summarized in Table 1 for both
the patient and the control groups. Allele distribution
analyses revealed significant associations between endo-
metriosis and genetic variations at three of the six SNPs
(Table 1). Endometriosis patients had significantly lower
frequencies of C allele at rs10794288, T allele at
rs10902088 and G allele at rs7103978, as compared to
the controls (P = 0.030, 0.013 and 0.040, respectively)
(Table 1). Genotype analysis indicated that frequency of
the TT genotype at rs10902088 was significantly lower
in patients than in controls (P = 0.045; OR = 0.47, 95%
CI: 0.27-0.83), while the CC genotype at rs10794288 and
the AG genotype at rs7103978 had protective effect
against endometriosis (OR = 0.56 and 0.47, respectively;
95% CI < 1) (Table 1). These results implied possible
relationship between three individual MUC2 polymorph-
isms and endometriosis development.
MUC2 polymorphisms and infertility
Because endometriosis was suggested as one source of
female infertility, we asked whether genetic variations in
MUC2 play roles in this process. The patients were sub-
grouped into patients with infertility or without inferti-
lity for genotype and allele distribution analyses.
Patients without sexual experience were excluded in this
study. As shown in Table 2, the C allele at rs10794288
and the T allele at rs10902088 were much less prevalent
in patients with infertility (P = 0.015 and 0.024, respec-
tively). The TT genotype at rs10902088 were absent in
the infertile patient group, and genotype distribution
was also significantly different between the infertile and
the fertile patients for this SNP (P = 0.047, data not
shown). This finding revealed protective potential of
these two genetic variations in MUC2 against infertility
in endometriosis patients.
Haplotype analysis of MUC2 polymorphisms
The endometriosis-related SNPs (rs10794288,
rs10902088 and rs7103978) found in individual tests
were selected for haplotype analysis of endometriosis
and disease-related clinical symptoms. Association data
were enlisted in Table 3 for all the haplotypes with fre-
quency higher than 1% presented in the case or control
group. As shown in Table 3, the two most common
haplotypes (T-C and C-T) of rs10794288 and
rs10902088 were significantly associated with both
endometriosis and infertility development in the
patients. Haplotype T-C was more common in endome-
triosis patients (P = 0.012) and patients with infertility
(P = 0.0091) (Table 3). By contrast, haplotype C-T
might be a protective factor against endometriosis (P =
0.035) and endometriosis-related infertility (P = 0.025)
(Table 3). Similarly, the most frequent haplotype T-C-A
of rs10794288, rs10902088 and rs7103978 was signifi-
cantly associated with both endometriosis (P = 0.0063)
and endometriosis-related infertility (P = 0.0066) as a
risk factor of the disease (Table 3). In the patient group,
LD map demonstrated higher linkage between these
three SNPs (Figure 1B) compared to the control group
(Figure 1A), suggesting a genetic relationship between
these SNPs and endometriosis. Therefore, haplotypes of
these SNPs in MUC2 gene could serve as an indicator
of susceptibility to endometriosis and endometriosis-
related infertility.
MUC2 polymorphisms and amino acid substitutions
One of the endometriosis-associated SNPs (rs1090
2088) in MUC2 gene caused an amino acid substitu-
tion (Additional file 1: Table S1), and functions of
MUC2 might be altered if such substitution changes
surface charge, protein stability or folding. This SNP
located at amino acid Asn1149, which was predicted to
be within a long coil region. The relative surface acces-
sibility of Asn1149 was estimated to be 0.707 with
reference to a fully exposed side chain, representing a
highly exposed residue. Genetic variation of
rs10902088 introduced an asparagine to lysine substi-
tution, which was well fit in this position as a highly
exposed residue, but the surface charge at this region
would be reversed. Accordingly, this substitution was
A B
Figure 1 Pairwise linkage disequilibrium (LD) between SNPs of
the MUC2 gene. LD maps were shown for controls (A) and
patients (B). Values shown are for D’.
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more likely to disrupt inter- or intra-molecular interac-
tions of MUC2 rather than protein stability. On the
other hand, rs10794288 and rs7103978 were silent
mutations, which only influence codon usages instead
of amino acid substitutions.
Discussion
Mucin proteins were known to be heavily glycosylated,
on which oligosaccharide structures turned to be
tumor-associated antigens and are essential for antibody
recognition [39-41]. Our data revealed two MUC2 poly-
morphisms (rs10794288 and rs10902088) were asso-
ciated with endometriosis development and the related
infertility. Polymorphism at rs10902088 generates an
amino-acid change Asn1149Lys, while rs10794288 is a
silent substitution. Although Asn1149 is not a typical
site for N-linked glycosylation, this substitution to posi-
tively charged residue may influence the glycosylation
states of several neighboring serines and Asn1154,
which is within a typical N-linked glycosylation tripep-
tide sequon Asn-Ile-Ser [42]. Therefore, this polymorph-
ism may alter the glycosylation status of MUC2, which
may subsequently influence the interaction between
MUC2 and host environments.
Table 1 Association between SNPs in MUC2 gene and endometriosis in Taiwanese patients and controls
SNP Genotype/allele No. (%) of patients No. (%) of controls p-valuea OR 95% CI
rs2856111 CC 35 (18.5) 35 (18.2) 0.29 0.79 0.46-1.36
CT 96 (50.8) 111 (57.8) 0.69 0.43-1.10
TT 58 (30.7) 46 (24.0) 1.00
C 166 (43.9) 181 (47.1) 0.37 0.88 0.66-1.17
T 212 (56.1) 203 (52.9) 1.00
rs11245936 AA 1 (0.5) 3 (1.6) 0.34 0.32 0.03-3.10
AG 21 (11.0) 28 (14.5) 0.72 0.39-1.32
GG 169 (88.5) 162 (83.9) 1.00
A 23 (6.0) 34 (8.8) 0.14 0.66 0.38-1.22
G 359 (94.0) 352 (91.2) 1.00
rs10794288 CC 34 (17.4) 45 (23.0) 0.092 0.56 0.33-0.96
CT 87 (44.6) 96 (49.0) 0.67 0.43-1.06
TT 74 (37.9) 55 (28.0) 1.00
C 155 (39.7) 186 (47.4) 0.030* 0.73 0.55-0.97
T 235 (60.3) 206 (52.6) 1.00
rs10902088 TT 27 (14.0) 43 (22.3) 0.045* 0.47 0.27-0.83
CT 93 (48.2) 95 (49.2) 0.74 0.47-1.16
CC 73 (37.8) 55 (28.5) 1.00
T 147 (38.1) 181 (47.4) 0.013* 0.70 0.52-0.93
C 239 (61.9) 205 (52.6) 1.00
rs7103978 GG 2 (1.0) 1 (0.5) 0.053 1.84 0.16-21.58
AG 19 (9.8) 37 (18.9) 0.47 0.26-0.85
AA 172 (89.1) 158 (80.6) 1.00
G 23 (6.0) 39 (9.9) 0.040* 0.57 0.34-0.98
A 363 (94.0) 353 (90.1) 1.00
rs11245954 GG 0 (0.0) 0 (0.0) NA NA NA
AG 21 (10.8) 26 (13.5) 0.78 0.42-1.43
AA 173 (89.2) 166 (86.5) 1.00
G 21 (5.4) 26 (6.8) 0.43 0.79 0.44-1.43
A 367 (94.6) 358 (93.2) 1.00
*Indicates statistical significance
aP-values were calculated using c2 test without corrections for multiple test
Table 2 Association between allele distributions of SNPs





P-valuea OR 95% CI
rs2856111 48.1 41.3 0.36 1.32 0.73-2.38
rs11245936 3.8 5.4 0.64 0.70 0.16-3.16
rs10794288 24.1 41.7 0.015* 0.44 0.23-0.87
rs10902088 26.0 43.1 0.024* 0.46 0.24-0.91
rs7103978 5.8 5.8 0.99 0.99 0.28-3.54
rs11245954 3.8 4.7 0.79 0.82 0.18-3.72
*Indicates statistical significance
MAF minor allele frequency
aP-values were calculated using c2 test
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Endometriosis development is associated with altered
inflammatory and immune responses, while clinical fea-
ture of endometriosis also mimics malignant reproduc-
tive disease, such as progressive invasion to adherent
pelvic organ and recurrence abilities. Mucins are
secreted by epithelium cells of reproductive tissues, gen-
erating the mucus of cervix and endometrium, which
plays an important role in reproductive physiology.
Impaired mucin secretion could impede spermatozoa
migration, which may contribute to female infertility.
Unlike the less consistent expression patterns of MUC1,
MUC6 and MUC5AC in normal and cancer tissues,
MUC2 levels were always measured low in normal
endometrial and cervical tissue, and elevated MUC2
expressions were specifically found in various neoplastic
lesions [28,29,43-45]. However, expression patterns of
MUC2 in ovarian tumor were heterogenic [18]. Boman
et al. reported that MUC2 were mainly present in
benign and borderline ovarian tumor [46], while Dong
et al. showed that breast cancer patients with presence
of MUC2 expression had shorter disease-free survival
[47]. We found that the minor allele of rs7103978
decreases the cognate codon frequency from 15.8‰ to
7.8‰ (Kazusa DNA Res. Inst. http://www.kazusa.or.jp/
codon/), which may increase the odds of premature
translation termination and thus reduce MUC2 level.
Therefore, our result suggested that expression of
MUC2 may facilitate cell invasion or proliferation abil-
ities. The observed association of MUC2 polymorphisms
and endometriosis may help us further elucidate the
link between endometriosis and certain subtypes of
ovarian cancer, if such genetic alterations were also pre-
sent in the ovarian cancer patients.
Although endometriosis could cause pelvic adhesion
and tubal occlusion which lead to infertility, some
patients without anatomic disruption still had the pro-
blem of impaired fertilization. Possible mechanisms of
endometriosis-related infertility include impaired follicu-
logenesis induced by abnormal immunological, chemical
factors or toxins, poor oocyte quality, inhibited binding
of spermatozoa to the zona-pellucida and impaired
implantation of embryo. This phenomenon was corre-
lated to changes of cytokines and growth factors in
endometrium, follicular fluid and peritoneal fluid [8].
Previous studies have already showed the positive asso-
ciation of endometriosis and polymorphism of cytokine
genes [7,48]. Li et al. showed that macrophage induced
IL-6 up-regulated the MUC1 but down-regulated MUC2
expression [9]. Up-regulation of MUC1 was associated
with implantation failure [22]. IL-1 was also found to
up-regulate MUC2 expression, and IL-1 was thought to
regulate immune and inflammation response in endo-
metrium and modulate extracellular matrix modeling of
endometrium during menstruation and implantation
[49]. Moreover, previous studies demonstrated that IL-8,
TNF-a and NF-B tend to increase in the peritoneal
fluid according to the severity of dysmenorrhea, extent
pelvic adhesion and proliferation of endometrial stroma
cells, and MUC2 expression could increase accordingly
via activation of NF-B pathway through these cytokines
[50-52]. Therefore, it is plausible that altered level of
MUC2 could affect fertility as a downstream effecter
that can further influence the secretion of mucus, sperm
motility, oocyte quality and receptivity of endometrium.
Conclusions
In this study, our data revealed a significant association
between MUC2 polymorphisms and endometriosis in a
Taiwanese population. The results imply that MUC2
may play a role in the pathogenesis of endometriosis
and endometriosis-related infertility, while the mechan-
isms underlying this phenomenon remain to be eluci-
dated. As a major secreted form of mucins, MUC2 may
have the ability to affect more surrounding tissues than
the membrane-bound form of mucins. Since MUC2 is
not as well investigated as some other mucins in repro-
ductive organs, its molecular function in endometriosis
and infertility is worth future study.
Table 3 Association between MUC2 haplotypes and endometriosis or endometriosis-related infertility
SNP marker Haplotype Endometriosis Endometriosis-related infertility
Case (%) Control (%) P-valuea Infertility (%) Non-infertility (%) P-valuea
rs10794288, rs10902088 T-C 58.6 49.6 0.012* 74.9 57.2 0.0091*
C-T 35.8 43.2 0.035* 23.4 38.3 0.025*
C-C 3.4 3.7 0.83 0.1 2.6 0.20
T-T 2.1 3.5 0.27 1.6 1.9 0.89
rs10794288, rs10902088, rs7103978 T-C-A 57.8 48.1 0.0063* 74.8 56.3 0.0066*
C-T-A 32.0 35.9 0.25 22.0 34.1 0.06
C-T-G 3.8 7.2 0.036* 1.4 4.2 0.29
C-C-A 3.4 3.7 0.81 0 2.6 0.20
T-T-G 1.5 2.0 0.61 1.6 1.1 0.76
*Indicates statistical significance. aP-values were calculated using c2 test
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Additional material
Additional file 1: Table S1. Probes been used for SNPs in MUC2 gene.
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